Russo 2021.

Study name	Efficacy and safety of smoking cessation with varenicline tartrate in diabetic smokers (DIASMOKE)
Methods	Randomised, double‐blind, placebo‐controlled trial
Participants	300 adults with type 2 diabetes, who smoke
Interventions	Varenicline 1 mg x 2/day for 12 weeks vs placebo
Outcomes	CA at week 24 and week 52; AEs
Starting date	June 2011
Contact information	Riccardo Polosa
Notes	Study funding: supported by grant WS5086648 from GRAND (Global Research Award for Nicotine Dependence), an independently reviewed competitive grants programme funded by Pfizer Inc.